Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer
NCT07407244
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
268
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Neoadjuvant Chemotherapy
Sponsor
Institute of Oncology Ljubljana